A lipidologist outlines how PREVENT, coronary calcium scoring, and restored LDL-C targets guide personalized lipid therapy and where pharmacists fit in.

Tim Ulbrich, PharmD, explains why a strong income alone doesn't guarantee financial progress and outlines 3 levers that have an outsized impact on building long-term wealth.

Experts discuss how pharmacists can apply shared clinical decision-making, address guidance fatigue, and build multi-vaccine programs as COVID-19 recommendations continue to evolve.

Trained technicians formalize social needs and cessation work already happening in pharmacies—but billing and credentialing remain the biggest hurdles.

Maroney and her guest, Danielle Stutzman, PharmD, BCPP, break down efficacy data and potential advantages of centanafadine, the newly approved triple reuptake inhibitor for ADHD.

Tim Ulbrich, PharmD, breaks down the 5 foundational components that pharmacists need in place before chasing more advanced financial optimization.

This episode covers the importance of considering vaccine timing, selection, and hesitancy in patients on immunomodulating and immunosuppressive therapies, along with emerging data linking several vaccines to reduced dementia risk.

From statins after 70 to aspirin-free STEMI care, the pharmacist takeaway across 13 trials: identify disease earlier, treat precisely, deliver reliably.

Craig Beavers, PharmD, breaks down CARDIO-TTRansform, SINGLE-AF, and POET II—and what each means for anticoagulation, stewardship, and monitoring.